About: Treatment Patterns and Clinical Outcomes Among Patients With HR+/HER2- mBC Receiving Palbociclib Combination Therapy in the US Community Oncology Setting.

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Treatment Patterns and Clinical Outcomes Among Patients With HR+/HER2- mBC Receiving Palbociclib Combination Therapy in the US Community Oncology Setting. Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

clinical trial

Attributes	Values
rdf:type	Item
description	clinical trial (en) ensayo clínico (es) ensayu clínicu (ast) klinisch onderzoek (nl) клінічне випробування (uk) կլինիկական փորձարկում (hy)
rdfs:label	Treatment Patterns and Clinical Outcomes Among Patients With HR+/HER2- mBC Receiving Palbociclib Combination Therapy in the US Community Oncology Setting. (en) Treatment Patterns and Clinical Outcomes Among Patients With HR+/HER2- mBC Receiving Palbociclib Combination Therapy in the US Community Oncology Setting. (nl)
skos:prefLabel	Treatment Patterns and Clinical Outcomes Among Patients With HR+/HER2- mBC Receiving Palbociclib Combination Therapy in the US Community Oncology Setting. (en) Treatment Patterns and Clinical Outcomes Among Patients With HR+/HER2- mBC Receiving Palbociclib Combination Therapy in the US Community Oncology Setting. (nl)
name	Treatment Patterns and Clinical Outcomes Among Patients With HR+/HER2- mBC Receiving Palbociclib Combination Therapy in the US Community Oncology Setting. (en) Treatment Patterns and Clinical Outcomes Among Patients With HR+/HER2- mBC Receiving Palbociclib Combination Therapy in the US Community Oncology Setting. (nl)
title	wds:Q106637744-612B9721-9698-448C-ADFD-A28311620C14
title	Treatment Patterns and Clinical Outcomes Among Patients With Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer (mBC) Receiving Palbociclib in Combination With Fulvestrant (PB+FUL) Or Fulvestrant Monotherapy (FUL Mono) In The US Community Oncology Setting (en)
end time	wds:Q106637744-DF5375D6-A039-41AD-BED2-F6FCADAEFEE6
end time	2021-04-30 00:00:00Z (xsd:dateTime)
instance of	wds:Q106637744-A89F29FF-9282-454D-80E3-EA7652086504
instance of	clinical trial
start time	wds:Q106637744-973DFDC3-2CE6-4D2F-824C-AA9807D89DD5
start time	2019-10-19 00:00:00Z (xsd:dateTime)
country	wds:Q106637744-9AF6D878-79CD-43B7-BDF9-49008993CE03
country	United States of America
sponsor	wds:Q106637744-B13CF49D-20DF-4BE0-9C52-748910204560
sponsor	Pfizer
number of participants	wds:Q106637744-B851AD0F-8FF9-437D-859A-B13D5DC3CF6D
number of participants	1 (xsd:decimal)
study type	wds:Q106637744-D636B1F1-EA32-4557-9D26-6937F5535506
study type	observational study
ClinicalTrials.gov ID	wds:Q106637744-5E3B6F7D-6E15-4B81-9ECD-73E0C8BEA0B1
ClinicalTrials.gov ID	NCT04460911
research subject recruitment status	wds:Q106637744-3E06BF76-216E-48A9-99D6-D49E75707BB6
research subject recruitment status	active, not recruiting
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q106637744

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 190 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software